Clinical Trial Update: Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19 [Phase 2]

View source ↗

Summary

Phase 2 trial update reports that camostat mesilate in hospitalized COVID-19 patients has completed, with results posted. The document also lists Severe Acute R…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syndrome

Drugs mentioned

• Camostat Mesilate (camostat mesilate)

Snippet

Sponsor: Alan Bryce | Conditions: Severe Acute Respiratory Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2024-11-12